Immunotherapy Offers Unseen Benefits: Reduces Advanced Cancers and Skin Lesions

A groundbreaking study conducted by University of Queensland researchers has uncovered an unexpected benefit of immunotherapy. This treatment, traditionally used to combat advanced cancers, has been found to significantly reduce sunspots and other forms of skin cancer.

How Immunotherapy Impacts Skin Health

Professor Kiarash Khosrotehrani from UQ’s Frazer Institute led the research, which focused on the effects of immunotherapy on patients’ skin health. The study monitored participants’ actinic keratoses, commonly known as sunspots, and keratinocyte carcinomas, a prevalent non-melanoma skin cancer.

The number of skin lesions on patients’ forearms were counted before starting immunotherapy, and then again at 3, 6, and 12-month intervals.

We found an 80% reduction in sunspots within 3 months, and an average 65% reduction in all patients by 12 months.

One patient’s precancerous lesions completely disappeared.

Professor Kiarash Khosrotehrani from UQ’s Frazer Institute

The Study Design and Methodology

The pilot study included patients undergoing intravenous immunotherapy for various advanced cancers, including melanoma, lung cancer, tonsillar, and renal cell carcinoma. The researchers were intrigued by the potential for immunotherapy to influence skin health, given its role in stimulating the immune system.

This is the first time researchers have quantified the impact of immunotherapy on skin cancers in a clinical setting, providing substantial evidence to support the therapy’s dual benefits.

Implications and Future Directions

Professor Khosrotehrani emphasized the study’s significance in exploring novel strategies for skin cancer prevention, particularly in high-risk individuals where traditional treatments are less effective. “This could pave the way for future clinical trials and offer new approaches to mitigating skin cancer risk.”

Dr Charlotte Cox, the lead author of the study, highlighted the urgency of finding new prevention methods. “Skin cancer is a widespread issue, affecting two-thirds of Australians by the age of 70, and costing the healthcare system $1.8 billion annually,” she explained. “Current therapies don’t prevent new skin cancers from developing on sun-damaged skin, but this research points to potential alternative prevention methods.”

The Numbers Speak: Reducing Skin Cancer Incidence

The 65% average reduction in sunspots and the reported complete disappearance of precancerous lesions in one patient underscore the substantial impact of immunotherapy on skin health. These findings suggest that immunotherapy could become a part of comprehensive skin cancer prevention strategies.

Given that current treatments focus on managing existing skin cancer cases rather than preventing their onset, this study opens a promising new frontier in skin cancer prevention.

Conclusion

The University of Queensland’s research is a testament to the multifaceted benefits of immunotherapy. By extending beyond its primary role in treating advanced cancers, immunotherapy can now be considered as a potential tool in the prevention of skin cancers and sunspots. This discovery has the potential to significantly reduce the burden of skin cancer, offering a healthier future for millions.

As this field of study continues to evolve, follow our coverage for updates and insights into how these findings could shape future medical practices.